Point-of-Care Testing and COVID-19: One-Shot or Long-Term Opportunity?
Sébastien Clerc,
Market & Technology Analyst,
Yole Développement
Abstract: The past few months have seen a new biological threat, the COVID-19 infection, caused by the SARS-CoV-2 virus, reshape the entire diagnostics ecosystem. Numerous companies rapidly started developing tests to detect the pathogen. But is point-of-care testing the real solution to identify early cases and stop the pandemic? Will there be a change in the use cases in the near future, like testing at the workplace, at the airport or in public transportation or public places? In this talk, Sébastien Clerc will share Yole’s vision of the point-of-care landscape and how the pandemic has impacted it.
|
|
